Your browser doesn't support javascript.
loading
Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin.
Nishikawa, Kazuhiro; Yamada, Yasuhide; Ishido, Kenji; Gotoh, Masahiro; Bando, Hideaki; Sugimoto, Naotoshi; Nishina, Tomohiro; Amagai, Kenji; Chin, Keisho; Niwa, Yasumasa; Tsuji, Akihito; Imamura, Hiroshi; Tsuda, Masahiro; Yasui, Hirofumi; Fujii, Hirofumi; Yamaguchi, Kensei; Yasui, Hisateru; Hironaka, Shuichi; Shimada, Ken; Miwa, Hiroto; Hamada, Chikuma; Hyodo, Ichinosuke.
Afiliación
  • Nishikawa K; Department of Surgery, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan. kazuno13@hotmail.co.jp.
  • Yamada Y; Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Ishido K; Department of Gastroenterology, Kitasato University East Hospital, Sagamihara, Japan.
  • Gotoh M; Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan.
  • Bando H; Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sugimoto N; Department of Clinical Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
  • Nishina T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Amagai K; Department of Gastroenterology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
  • Chin K; Department of Gastroenterology, Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Niwa Y; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Tsuji A; Department of Medical Oncology, Kochi Health Sciences Center, Kochi, Japan.
  • Imamura H; Department of Surgery, Sakai City Hospital, Sakai, Japan.
  • Tsuda M; Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan.
  • Yasui H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Sunto-Gun, Japan.
  • Fujii H; Division of Clinical Oncology, Jichi Medical University, Shimotsuke, Japan.
  • Yamaguchi K; Division of Gastroenterology, Saitama Cancer Center, Kita-Adachi-Gun, Japan.
  • Yasui H; Department of Medical Oncology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Hironaka S; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Shimada K; Department of Internal Medicine, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Miwa H; Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Hamada C; Faculty of Engineering, Tokyo University of Science, Tokyo, Japan.
  • Hyodo I; Division of Gastroenterology, University of Tsukuba, Tsukuba, Japan.
Gastric Cancer ; 20(4): 640-645, 2017 Jul.
Article en En | MEDLINE | ID: mdl-27822684
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón